Viviana Giannuzzi, head of the research department at Fondazione Gianni Benzi, contributed as co-editor to the research topic “Reviews in: Regulatory Science” on the journal Frontiers in Medicine – Regulatory Science.

The editorial article has just been published with relevant world-wide highlights on regulatory science.

The aim of the selection was to cover a broad variety of regulatory challenges emerging from the development of various nucleic acid-based drugs, oncological agents, the evidence-based evaluation of herbal medicinal products, the impact of pharmacogenetic programs on healthcare and finally linking their marketing approval to the speed of pricing and reimbursement decisions.

This special collection has successfully published 8 manuscripts with researchers from different countries and continents reporting examples of the latest knowledge in regulatory science.

According to the Editors, combining these articles dealing with various aspects of drug development spanning from the bench to the patients, from the clinical studies through the regulatory decision and health technology assessment to the broad healthcare application will support this complex process.

Moreover, joint publication of these papers demonstrates that the decisions made at the different steps must consider the entire developmental process including also their social and ethical impacts.

Read the editorial article here!